D.E. Shaw & Co’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-329,923
| Closed | -$1.02M | – | 6274 |
|
|
2021
Q4 | $1.02M | Buy |
329,923
+195,875
| +146% | +$659K | ﹤0.01% | 3914 |
|
|
2021
Q3 | $484K | Sell |
134,048
-52,507
| -28% | -$198K | ﹤0.01% | 4103 |
|
|
2021
Q2 | $668K | Buy |
186,555
+11,721
| +7% | +$41.4K | ﹤0.01% | 3861 |
|
|
2021
Q1 | $684K | Sell |
174,834
-140,437
| -45% | -$580K | ﹤0.01% | 3358 |
|
|
2020
Q4 | $1.32M | Sell |
315,271
-73,231
| -19% | -$282K | ﹤0.01% | 2842 |
|
|
2020
Q3 | $1.45M | Sell |
388,502
-130,473
| -25% | -$555K | ﹤0.01% | 2613 |
|
|
2020
Q2 | $2.26M | Sell |
518,975
-47,363
| -8% | -$213K | ﹤0.01% | 2324 |
|
|
2020
Q1 | $2.15M | Sell |
566,338
-709,169
| -56% | -$3.48M | ﹤0.01% | 2106 |
|
|
2019
Q4 | $8.06M | Buy |
1,275,507
+279,252
| +28% | +$1.64M | 0.01% | 1360 |
|
|
2019
Q3 | $4.19M | Sell |
996,255
-82,491
| -8% | -$352K | 0.01% | 1784 |
|
|
2019
Q2 | $5.02M | Sell |
1,078,746
-288,733
| -21% | -$1.34M | 0.01% | 1591 |
|
|
2019
Q1 | $7.25M | Buy |
1,367,479
+930,350
| +213% | +$4.25M | 0.01% | 1308 |
|
|
2018
Q4 | $1.62M | Buy |
437,129
+275,894
| +171% | +$969K | ﹤0.01% | 2328 |
|
|
2018
Q3 | $451K | Buy |
161,235
+74,037
| +85% | +$208K | ﹤0.01% | 3167 |
|
|
2018
Q2 | $257K | Buy |
87,198
+52,738
| +153% | +$125K | ﹤0.01% | 3449 |
|
|
2018
Q1 | $78K | Buy |
+34,460
| New | +$80.7K | ﹤0.01% | 3408 |
|
|
2015
Q4 | – | Sell |
-59,031
| Closed | -$328K | – | 4146 |
|
|
2015
Q3 | $328K | Sell |
59,031
-52,530
| -47% | -$388K | ﹤0.01% | 3313 |
|
|
2015
Q2 | $888K | Buy |
111,561
+88,350
| +381% | +$759K | ﹤0.01% | 2791 |
|
|
2015
Q1 | $244K | Buy |
+23,211
| New | +$317K | ﹤0.01% | 3382 |
|
|
2014
Q4 | – | Sell |
-32,983
| Closed | -$564K | – | 4541 |
|
|
2014
Q3 | $564K | Buy |
+32,983
| New | +$479K | ﹤0.01% | 3263 |
|
|
2013
Q3 | – | Sell |
-46,935
| Closed | -$191K | – | 4655 |
|
|
2013
Q2 | $191K | Buy |
+46,935
| New | +$220K | ﹤0.01% | 3773 |
|
Other funds holding BDSI
D.E. Shaw & Co's BDSI Position: Q1 2022 in Review
D.E. Shaw & Co sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 329,923 shares — an estimated $1.02M sold.
D.E. Shaw & Co first reported a position in BDSI in Q2 2013 and held it in 21 quarters. The position peaked at $8.06M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- D.E. Shaw & Co reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 329,923 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1.02M.
- D.E. Shaw & Co first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 21 quarters.
- D.E. Shaw & Co's BioDelivery Sciences International, Inc. position peaked at $8.06M in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.